³ë¸¥ÀÚ¸ð¾çȲ¹Ýº¯¼º ȯÀÚ¿¡¼ À¯¸®Ã¼°³» º£¹Ù½ÃÁÖ¸¿ ÁÖÀÔ¼úÀ» ½ÃÇàÇÑ È¯ÀÚ 1¿¹
A Case of Adult?Onset Vitelliform Dystrophy Treated with Intravitreal Injection of Bevacizumab
´ëÇѾȰúÇÐȸÁö 2014³â 55±Ç 7È£ p.1093 ~ p.1098
¹®»ó¿ì(Moon Sang-Woo) - ÀÎÁ¦´ëÇб³ ÀÇ°ú´ëÇÐ ºÎ»ê¹éº´¿ø ¾È°úÇб³½Ç
ÀÌÈ£¿µ(Lee Ho-Young) - ½Å¼¼°è¾È°úÀÇ¿ø
À±ÀÏÇÑ(Yun Il-Han) - ÀÎÁ¦´ëÇб³ ÀÇ°ú´ëÇÐ ºÎ»ê¹éº´¿ø ¾È°úÇб³½Ç
ÀÓ¼ºÇù(Lim Sung-Hyup) - ÀÎÁ¦´ëÇб³ ÀÇ°ú´ëÇÐ ºÎ»ê¹éº´¿ø ¾È°úÇб³½Ç
Abstract
Purpose: To report a patient diagnosed with adult-onset vitelliform dystrophy (AOVD) who received an intravitreal injection of bevacizumab in both eyes.
Case summary: A 47-year-old female presented with blurred vision and metamorphopsia in both eyes. On color fundus photograph, small, round, yellowish dots on the foveola and subreitnal fluid were observed. Optical coherence tomography (OCT) showed thick hyperreflective structures in the retinal pigment epithelium (RPE) layer with serous retinal detachment and subretinal fluid. Despite an intravitreal injection of bevacizumab on both eyes, anatomical improvement was not observed on fundus photography and OCT.
Å°¿öµå
Bevacizumab, Vitelliform macular dystrophy
KMID :
0360220140550071093
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
À¯È¿¼º°á°ú(Recomendation)